{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:02:12Z","timestamp":1770822132190,"version":"3.50.1"},"reference-count":18,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2003,1,24]],"date-time":"2003-01-24T00:00:00Z","timestamp":1043366400000},"content-version":"vor","delay-in-days":23,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2003,1]]},"abstract":"<jats:p>The <jats:italic>BCR\u2013ABL\u2010<\/jats:italic>negative chronic myeloproliferative disorders (CMPD) and myelodysplastic\/myeloproliferative diseases (MDS\/MPD) are a spectrum of related conditions for which the molecular pathogenesis is poorly understood. Translocations that disrupt and constitutively activate the platelet\u2010derived growth factor receptor \u03b2<jats:bold>(<\/jats:bold><jats:italic>PDGFRB<\/jats:italic>) gene at chromosome band 5q33 have been described in some patients, the most common being the t(5;12)(q33;p13). An accurate molecular diagnosis of <jats:italic>PDGFRB<\/jats:italic>\u2010rearranged patients has become increasingly important since recent data have indicated that they respond very well to imatinib mesylate therapy. In this study, we have tested nine patients with a CMPD or MDS\/MPD and a translocation involving 5q31\u201333 for disruption of <jats:italic>PDGFRB<\/jats:italic> by two\u2010colour fluorescence <jats:italic>in situ<\/jats:italic> hybridization (FISH) using differentially labelled, closely flanking probes. Normal control interphase cells gave a false positive rate of 3% (signals more than one signal width apart). Six patients showed a pattern of one fused signal (from the normal allele) and one pair of signals separated by more than one signal width in &gt;\u200a85% of interphase cells, indicating that <jats:italic>PDGFRB<\/jats:italic> was disrupted. These individuals had a t(1;5)(q21;q33), t(1;5)(q22;q31), t(1;3;5)(p36;p21;q33), t(2;12;5)(q37;q22;q33), t(3;5) (p21;q31) and t(5;14)(q33;q24) respectively. The remaining three patients with a t(1;5)(q21;q31), t(2;5)(p21;q33) and t(5;6)(q33;q24\u201325) showed a normal pattern of hybridization, with \u2265\u200397% interphase cells with two fusion signals. We conclude that two\u2010colour FISH is useful to determine the presence of a <jats:italic>PDGFRB<\/jats:italic> rearrangement, although, as we have shown previously, this technique may not detect subtle complex translocations at this locus. Our data indicate that several <jats:italic>PDGFRB<\/jats:italic> partner genes remain to be characterized.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2003.04051.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:50:30Z","timestamp":1047365430000},"page":"251-256","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["Novel translocations that disrupt the platelet\u2010derived growth factor receptor \u03b2 (PDGFRB) gene in BCR\u2013ABL\u2010negative chronic myeloproliferative disorders"],"prefix":"10.1111","volume":"120","author":[{"given":"E. Joanna","family":"Baxter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shashikant","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9\u2010Luis","family":"Vizmanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rina","family":"Jaju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoletta","family":"Testoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoryana","family":"Salamanchuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Jos\u00e9","family":"Calasanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Idoya","family":"Lahortiga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher F.","family":"Pocock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond","family":"Dang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carrie","family":"Fidler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James S.","family":"Wainscoat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Boultwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas C. P.","family":"Cross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,1,24]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.1182\/blood.V90.11.4271","article-title":"Fusion of the platelet\u2010derived growth factor receptor beta to a novel gene CEV14 in acute myelogenous leukemia after clonal evolution","volume":"90","author":"Abe A.","year":"1997","journal-title":"Blood"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020150"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.150079597"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2264(199704)18:4<246::AID-GCC2>3.0.CO;2-0"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V93.3.1025"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.5.1776"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402556"},{"key":"e_1_2_12_9_1","first-page":"186","article-title":"An optimised multiplex polymerase chain reaction for detection of BCR\u2010ABL fusion mRNAs in haematological disorders","volume":"8","author":"Cross N.C.P.","year":"1994","journal-title":"Leukemia"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1987.tb01331.x"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(94)90322-0"},{"key":"e_1_2_12_12_1","first-page":"3592","article-title":"Fusion of H4\/D10S170 to the platelet\u2010derived growth factor receptor beta in BCR\u2010ABL\u2010negative myeloproliferative disorders with a t(5;10)(q33;q21)","volume":"60","author":"Kulkarni S.","year":"2000","journal-title":"Cancer Research"},{"key":"e_1_2_12_13_1","first-page":"157","volume-title":"Human Cytogenetics: A Practical Approach","author":"Lichter P.","year":"1992"},{"key":"e_1_2_12_14_1","first-page":"651","article-title":"AlphaIFN\u2010induced hematologic and cytogenetic remission in chronic eosinophilic leukemia with t(1;5)","volume":"84","author":"Luciano L.","year":"1999","journal-title":"Haematologica"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.8.2518"},{"key":"e_1_2_12_16_1","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1182\/blood.V91.12.4419","article-title":"Fusion of Huntington interacting protein 1 to platelet\u2010derived growth factor beta receptor (PDGFbetaR) in chronic myelomonocytic leukemia with t(5;7)(q33;q11.2)","volume":"91","author":"Ross T.S.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.12.3910"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1159\/000046641"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb03392.x"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2003.04051.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2003.04051.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2003.04051.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T17:42:53Z","timestamp":1697391773000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2003.04051.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["10.1046\/j.1365-2141.2003.04051.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2003.04051.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,1]]},"assertion":[{"value":"2003-01-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}